Amino Acid Analysis vs Peptide Sequencing: Composition and Order
Learn why amino acid analysis measures composition, how hydrolysis changes results, and what additional evidence supports peptide sequence.

Amino acid analysis measures which amino acids are present and their amounts; peptide sequencing investigates their order in a chain. After complete hydrolysis, the original positional information is lost. Composition can support a specified peptide’s quantity or reveal a mismatch, but a matching composition does not establish the full sequence, terminal chemistry or every structural feature.
The difference begins with what happens to the chain
For hydrolysed amino acid analysis, an intact peptide is converted into released amino acids before those amino acids are separated and measured. The resulting report can describe quantities or relative composition. It is not a list of residues read successively from the original molecule.
Waters’ hydrolysis primer explains that peptide-bond cleavage and amino-acid recovery depend on the chemistry of the procedure. It describes acid, alkaline and other approaches rather than one preparation that recovers every residue identically. This matters because the composition table is the outcome of a preparation and measurement, not a direct transcription of the original chain. [1]
Sequencing needs information that connects residues to positions. Tandem mass spectrometry can generate fragments containing different portions of a chain. Interpreting those fragments can provide sequence-related evidence; the scope depends on the observed fragments, their assignments and the analytical method.
Thermo Fisher’s first-party fragment documentation describes fragment spectra from peptide-bond cleavage and the fragment series used in sequence interpretation. A diagram of the proposed sequence is therefore different evidence from a measured spectrum that supports its individual assignments. [2]
Same composition, different sequence: a small counterexample
Invented linear peptides: consider H-Ala-Gly-Lys-Ala-OH and H-Ala-Lys-Gly-Ala-OH, with the same terminal groups and residue configurations. Each contains two alanines, one glycine and one lysine. Complete hydrolysis followed by ideal recovery gives the same counts for both.
| Observation | Ala-Gly-Lys-Ala | Ala-Lys-Gly-Ala |
|---|---|---|
| Ala residues per chain | 2 | 2 |
| Gly residues per chain | 1 | 1 |
| Lys residues per chain | 1 | 1 |
| Position 2 | Gly | Lys |
| Composition agreement | The expected amino-acid totals are identical | |
For the first chain, the first two residues are Ala-Gly; for the second, they are Ala-Lys. Evidence for an appropriately assigned fragment containing that region could help distinguish them. Counting all released Gly and Lys cannot restore their earlier positions because hydrolysis has discarded the connection.
This example also explains why composition agreement can be useful without being conclusive. A completely different amino-acid count could contradict the proposed material. But several candidate structures can satisfy the same count, so agreement narrows a question rather than answering every identity question.
Hydrolysis can change the labels being counted
Under conventional hydrochloric-acid hydrolysis, Asn and Gln can become Asp and Glu. Tryptophan can be destroyed, and sulfur-containing residues need particular attention. The severity and recoverability depend on the conditions and pretreatment; do not describe these as unavoidable losses under every possible amino-acid method. [1]
Texas A&M’s Protein Chemistry Laboratory describes a hydrolysed assay reporting Asn/Gln through ASX/GLX categories, while its free-amino-acid analysis omits hydrolysis. It also identifies separate procedures for residues requiring special handling. A report’s preparation and reporting categories therefore belong beside the numerical results. [3]
For an invented peptide containing one Asp and two Asn residues, a combined Asp/Asn-derived category could represent three residue equivalents after the specified conversion. That observation alone cannot show which of the original three positions held Asn. It also cannot prove that the sample was deamidated before analysis; the preparation itself may explain the combined category.
Similarly, a missing Trp result under a procedure that does not preserve it is not evidence that the starting sequence lacked Trp. The useful question is whether the laboratory intended to measure that residue with an appropriate method. A blank cell, an excluded analyte and a measured zero should remain distinct in an extracted data table.
Separate incomplete release from destruction after release
Two different limitations can reduce an amino-acid result. A residue may not be fully released from the original material, or it may be altered during preparation. A smaller measured amount alone does not identify which process occurred. Calling every low recovery “degradation of the supplied peptide” would add a causal claim the measurement has not established.
The UC Davis Molecular Structure Facility describes its standard acid-hydrolysis workflow and alternative procedures for Trp, Cys and Met. Its documentation also notes sample incompatibilities and interference. These are method-specific service descriptions, useful for understanding why preparation details matter rather than assuming all amino-acid reports have identical coverage. [4]
For a research report, retain the hydrolysis method, targeted amino acids, any pretreatment and the laboratory’s stated limitations. If several residues produce inconsistent estimates of peptide amount, that inconsistency should remain visible. It could motivate further investigation without immediately proving a wrong sequence or identifying a particular impurity.
Worked example: composition can support an amount estimate
Hypothetical calculation, with deliberately ideal assumptions: a known peptide contains two Ala, one Gly and one Lys per chain. Suppose a validated analysis, appropriately corrected for blanks and preparation performance, attributes 20.0 nmol Ala, 10.0 nmol Gly and 10.0 nmol Lys to an analysed aliquot.
The chain-equivalent estimates are 20.0/2 = 10.0 nmol from Ala, 10.0/1 = 10.0 nmol from Gly and 10.0/1 = 10.0 nmol from Lys. Their agreement is consistent with the proposed stoichiometry. It does not distinguish the two sequence arrangements in the earlier table, because both have that stoichiometry.
Now change only the hypothetical Ala result to 16.0 nmol. The Ala-based estimate becomes 8.0 nmol while the other two remain 10.0 nmol. Averaging them immediately would obscure the disagreement. First ask whether the chosen residues were suitable quantitative markers, whether the preparation and calibration were adequate, and whether other sample components contributed.
A mixture is an especially important ambiguity. Free amino acids or another peptide can contribute to the same measured amino-acid pool. The conversion from residue amount to target-chain amount therefore assumes that the relevant contribution belongs to the defined target, or that other contributions have been appropriately separated or accounted for.
Quantification is not automatically a powder-purity result
The worked example concerns an analysed aliquot, not every gram in a vial. Extending it to the starting material requires the preparation volume, aliquot fraction and a defined molecular-mass basis where conversion to mass is needed. Any terminal chemistry or modification included in that molecular specification must be handled consistently.
Waters’ first-party application experiment compares amino-acid composition and concentration results with expectations for a known protein. It illustrates a quantitative use of amino-acid analysis; it does not establish that an arbitrary unknown mixture can be assigned a complete sequence or target-specific mass fraction by the same arithmetic. [5]
Do not substitute “HPLC purity” for the assigned concentration in this reasoning. Amino-acid amount, peptide-chain equivalent and chromatographic area fraction have different definitions. See peptide purity versus content and calibration and reference standards for those complementary questions.
What evidence should a sequencing claim retain?
A useful sequencing summary identifies the method, proposed sequence, sample and extent of supporting evidence. For MS/MS, ask which regions are supported by observed fragment assignments and which remain ambiguous. The fact that software can display a complete candidate chain does not show that every position was independently established.
Also distinguish testing an expected sequence from reconstructing an unknown sequence. A database or targeted comparison begins with candidate information; de novo interpretation asks a different computational question. Both can be informative, but a report should preserve the actual approach rather than relabelling every mass-spectrum comparison “full sequencing.”
Composition and positional evidence can complement each other. An unexpected composition can flag a problem even when a sequence assignment appears attractive. Conversely, a composition match cannot fill a gap in positional coverage. Agreement across methods is most useful when their independent limitations remain explicit.
Common questions
Does amino-acid analysis confirm the exact sequence?
No. A composition result does not preserve residue order after complete hydrolysis. It can support consistency with an expected composition while leaving several sequences possible.
Does an absent Trp entry prove a missing Trp residue?
No. Check whether the preparation preserves Trp and whether it was included in the assay. A method limitation is different from a demonstrated absence in the original material.
Why might Asn and Asp appear in one reported category?
Some hydrolysis workflows convert Asn to Asp. A combined category must be interpreted using that preparation, rather than read as a direct record of original residue identity at each position.
Can AAA quantify a peptide when its sequence is known?
It can support a quantity under appropriate methods and assumptions, including suitable residue markers and accounted-for contributions from other material. Knowing a sequence alone does not validate the complete measurement.
Does a matching intact mass replace sequencing?
No. Different sequences can share an intact mass. The MS identity guide explains the distinction between mass agreement and broader structural evidence.
Related reading and scope
Use LOD versus LOQ when interpreting missing or below-range results, and continue through the peptide science library. This educational guide contains original hypothetical reasoning, not supplier-batch testing. HealthyWelness operates a commercial research-material catalog; no particular analytical service, certification or accreditation is asserted.
Cover: AI-generated conceptual editorial artwork, not an exact molecular structure, measured result or a photograph of HealthyWelness staff or facilities.